Cannabis with high levels of tetrahydrocannabinol is associated with short-term improvement in pain vs placebo, but also increased side effects, according to a newly updated review.
In light of President Donald Trump’s December executive order urging for the reclassification of cannabis to a Schedule III narcotic, the nation likely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback